NCT06554405

Brief Summary

This study aims to investigate whether bilateral (both extremities together) neuromobilization is superior to unilateral (only the affected side) neuromobilization in individuals diagnosed with Carpal Tunnel Syndrome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 12, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 15, 2024

Completed
16 days until next milestone

Study Start

First participant enrolled

August 31, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2025

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2025

Completed
Last Updated

December 24, 2025

Status Verified

February 1, 2025

Enrollment Period

9 months

First QC Date

August 12, 2024

Last Update Submit

December 18, 2025

Conditions

Keywords

Carpal Tunnel SyndromeNeuromobilizationMedian Nerve

Outcome Measures

Primary Outcomes (1)

  • Symptom Severity Assessment (Boston Carpal Tunnel Syndrome Questionnaire- Symptom Severity Scale)

    The Boston Carpal Tunnel Syndrome Questionnaire (BCTSQ), developed in 1993, will be used to assess individuals' functional status and symptoms. The Turkish validity and reliability study of the test has been conducted. The test consists of two self-assessment sections: one with 11 questions evaluating symptom severity and another with 8 questions evaluating functional capacity. It is a Likert-type questionnaire, where 1 indicates the best condition and 5 indicates the worst condition. The total score is calculated by dividing the total points by the number of questions, resulting in a score between 1 and 5.

    Four weeks

Secondary Outcomes (5)

  • Light Touch and Pressure Sense

    Four weeks

  • Visual Analog Scale (VAS)

    Four weeks

  • Gross Grip Strength

    Four weeks

  • Pinch Grip Strength

    Four weeks

  • Functional Level Assessment (Boston Carpal Tunnel Syndrome Questionnaire-Functional Status Scale)

    Four weeks

Study Arms (2)

Unilateral Intervention

ACTIVE COMPARATOR

Patients will be treated for 4 weeks (2 days in a week, 8 sessions). The treatment plan involves massage therapy, neuromobilization exercises and cold application. In this arm, treatment plan will be applied only for the symptomatic side. The rest of the treatment will be the same as the other group.

Other: Unilateral Intervention

Bilateral Intervention

EXPERIMENTAL

Patients will be treated for 4 weeks (2 days in a week, 8 sessions). The treatment plan involves massage therapy, neuromobilization exercises and cold application. In this arm, treatment plan will be applied only for both symptomatic and nonsymptomatic sides. The rest of the treatment will be the same as the other group.

Other: Bilateral Intervention

Interventions

Treatment plan will be applied to the symptomatic side.

Unilateral Intervention

Treatment plan will be applied to the symptomatic and nonsymptomatic sides.

Bilateral Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals diagnosed with CTS,
  • Aged 18 and above,
  • Without any other conditions in either upper extremity (such as trigger finger, osteoarthritis, tenosynovitis)

You may not qualify if:

  • Individuals with a history of surgery, trauma, or fracture in the same upper extremity,
  • Those who have received an injection for CTS in the last 3 months,
  • Those with poor cooperation,
  • Those participating in any other treatment program during the study,
  • Those with a history of uncontrolled systemic diseases or systemic diseases involved in the etiology of CTS (such as diabetes, thyroid diseases, rheumatoid arthritis),
  • Those who have used orthoses regularly and/or received physiotherapy in the last 3 months,
  • Individuals with marked thenar atrophy requiring early surgical intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gazi University Faculty of Health Sciences

Ankara, Ankara, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Carpal Tunnel Syndrome

Condition Hierarchy (Ancestors)

Median NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and Injuries

Study Officials

  • Öznur GÜNEY

    Zonguldak Bulent Ecevit University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The researcher who will evaluate the patients before and after treatment will not know which group the patients are in.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be grouped according to randomization into unilateral or bilateral intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

August 12, 2024

First Posted

August 15, 2024

Study Start

August 31, 2024

Primary Completion

May 30, 2025

Study Completion

June 20, 2025

Last Updated

December 24, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations